Literature DB >> 11078708

Properties of CFTR activated by the xanthine derivative X-33 in human airway Calu-3 cells.

L Bulteau1, R Dérand, Y Mettey, T Métayé, M R Morris, C M McNeilly, C Folli, L J Galietta, O Zegarra-Moran, M M Pereira, C Jougla, R L Dormer, J M Vierfond, M Joffre, F Becq.   

Abstract

The pharmacological activation of the cystic fibrosis gene protein cystic fibrosis transmembrane conductance regulator (CFTR) was studied in human airway epithelial Calu-3 cells, which express a high level of CFTR protein as assessed by Western blot and in vitro phosphorylation. Immunolocalization shows that CFTR is located in the apical membrane. We performed iodide efflux, whole cell patch-clamp, and short-circuit recordings to demonstrate that the novel synthesized xanthine derivative 3, 7-dimethyl-1-isobutylxanthine (X-33) is an activator of the CFTR channel in Calu-3 cells. Whole cell current activated by X-33 or IBMX is linear, inhibited by glibenclamide and diphenylamine-2-carboxylate but not by DIDS or TS-TM calix[4]arene. Intracellular cAMP was not affected by X-33. An outwardly rectifying Cl(-) current was recorded in the absence of cAMP and X-33 stimulation, inhibited by DIDS and TS-TM calix[4]arene. With the use of short-circuit recordings, X-33 and IBMX were able to stimulate a large concentration-dependent CFTR transport that was blocked by glibenclamide but not by DIDS. Our results show that manipulating the chemical structure of xanthine derivatives offers an opportunity to identify further specific activators of CFTR in airway cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11078708     DOI: 10.1152/ajpcell.2000.279.6.C1925

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  5 in total

1.  Metabolomic profiling reveals biochemical pathways and biomarkers associated with pathogenesis in cystic fibrosis cells.

Authors:  Diana R Wetmore; Elizabeth Joseloff; Joseph Pilewski; Douglas P Lee; Kay A Lawton; Matthew W Mitchell; Michael V Milburn; John A Ryals; Lining Guo
Journal:  J Biol Chem       Date:  2010-07-30       Impact factor: 5.157

2.  Mutation-specific potency and efficacy of cystic fibrosis transmembrane conductance regulator chloride channel potentiators.

Authors:  Antonella Caputo; Alexandre Hinzpeter; Emanuela Caci; Nicoletta Pedemonte; Nicole Arous; Marco Di Duca; Olga Zegarra-Moran; Pascale Fanen; Luis J V Galietta
Journal:  J Pharmacol Exp Ther       Date:  2009-06-02       Impact factor: 4.030

3.  Comparative pharmacology of the activity of wild-type and G551D mutated CFTR chloride channel: effect of the benzimidazolone derivative NS004.

Authors:  R Dérand; L Bulteau-Pignoux; F Becq
Journal:  J Membr Biol       Date:  2003-07-15       Impact factor: 1.843

4.  Activation of VPAC1 receptors by VIP and PACAP-27 in human bronchial epithelial cells induces CFTR-dependent chloride secretion.

Authors:  Renaud Dérand; Alicia Montoni; Laurence Bulteau-Pignoux; Thierry Janet; Bertrand Moreau; Jean-Marc Muller; Frédéric Becq
Journal:  Br J Pharmacol       Date:  2004-01-26       Impact factor: 8.739

5.  Correction of G551D-CFTR transport defect in epithelial monolayers by genistein but not by CPX or MPB-07.

Authors:  Olga Zegarra-Moran; Leila Romio; Chiara Folli; Emanuela Caci; Frederic Becq; Jean-Michel Vierfond; Yvette Mettey; Giulio Cabrini; Pascale Fanen; Luis J V Galietta
Journal:  Br J Pharmacol       Date:  2002-10       Impact factor: 8.739

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.